NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/09/2025
Voltar para busca
Dado oficial do USPTO
HCG SELECT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
10/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36
Data de depósito
16/03/2023
Data de registro
09/09/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/09/2025
Última transação
10/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/05/2023
Primeiro uso no comércio
01/05/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
San Diego, CA
Examinador
JARAMILLO, JAVIER
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
MedImpact Healthcare Systems, Inc.
Representantes
Susan B. Meyer GORDON REES SCULLY MANSUKHANI LLP
Classificação técnica
Classes Nice
Classe 35Classe 36
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Administering healthcare management programscost management and consultation for the healthcare and prescription drug benefit plans of others; administering healthcare management programscost management for the healthcare benefit plans of others via healthcare and prescription drug benefit plan utilization review programs and pharmaceutical cost management services; administering healthcare management programscost management for the healthcare benefit plans of others via drug utilization review programs; administering healthcare management programscost management for the healthcare benefit plans of others featuring prescription drug mail order and specialty drug programs and integrated healthcare wellness programs; Healthcare benefit management services in the nature of healthcare cost reviewmonitoring and analyzing information regarding consumer prescription drug use and healthcare habits to identify potential cost savings and improvements to business administration of integrated healthcare wellness programs
Classe 36
Healthcare benefit management servicesinsurance administration and insurance claims processing of healthcare and prescription drug benefit plans; Healthcare benefit management servicesadministering a network of pharmacy providers for the purpose of insurance administration of healthcare benefits; Healthcare benefit management servicesinsurance advisory services and insurance consultancy regarding healthcare and prescription drug benefit plans; Healthcare benefit management servicesprovision of insurance information and analysis in the fields of healthcare and prescription drug benefits; Healthcare benefit management servicesinsurance claims processing for healthcare benefits in the nature of verification and processing of consumer healthcare benefits and prior authorization requests
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/09/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
19/08/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
19/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/08/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/08/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
18/08/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
23/05/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
23/05/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/02/2025
GNFR
FINAL REFUSAL E-MAILED
28/02/2025
CNFR
SU - FINAL REFUSAL - WRITTEN
28/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/01/2025
ALIE
ASSIGNED TO LIE
28/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/01/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/10/2024
GNRT
NON-FINAL ACTION E-MAILED
17/10/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
17/10/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/10/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/10/2024
IUAF
USE AMENDMENT FILED
30/07/2024
EISU
TEAS STATEMENT OF USE RECEIVED
30/07/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/12/2023
PUBO
PUBLISHED FOR OPPOSITION
05/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/10/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
17/08/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
17/08/2023
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
25/05/2023
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
25/05/2023
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
25/05/2023
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
25/05/2023
DOCK
ASSIGNED TO EXAMINER
22/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/04/2023
NWAP
NEW APPLICATION ENTERED
20/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HCG SELECT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.